Pathogenesis of inflammation and repair in advanced COPD

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 3, 2010, Pages 257-266

  Cornwell, William D ^a   Kim, Victor ^a   Song, Changcheng ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Chronic obstructive pulmonary disease; Cytokines; Inflammatory cells; Oxidative stress

Indexed keywords

CATALASE; CD1C ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CIGARETTE SMOKE; CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; MALONALDEHYDE; SCATTER FACTOR; SUPEROXIDE DISMUTASE; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

AIRWAY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DENDRITIC CELL; DESTRUCTION; HUMAN; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG FUNCTION; LUNG PARENCHYMA; MACROPHAGE; NEUTROPHIL; NOCICEPTIVE STIMULATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SMOKING CESSATION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

ANIMALS; APOPTOSIS; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES, OBSTRUCTIVE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SMOKING CESSATION; UP-REGULATION;

EID: 77953305587     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1254066     Document Type: Review

References (100)

1. Pauwels R A., Buist A S., Ma P, Jenkins C R., Hurd S S., GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001 46 798-825
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977 1 1645-1648
3. Xu X, Weiss S T., Rijcken B, Schouten J P. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J 1994 7 1056-1061
4. American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996 153 861-865
5. Larsson K. Aspects on pathophysiological mechanisms in COPD. J Intern Med 2007 262 311-340
6. Quint J K., Wedzicha J A. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2007 119 1065-1071
7. Barnes P J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008 8 183-192
8. Beeh K M., Kornmann O, Buhl R, Culpitt S V., Giembycz M A., Barnes P J. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 2003 123 1240-1247
9. Tanino M, Betsuyaku T, Takeyabu K et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002 57 405-411
10. Traves S L., Culpitt S V., Russell R E., Barnes P J., Donnelly L E. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002 57 590-595
11. Hartl D, Latzin P, Hordijk P et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007 13 1423-1430
12. Qiu Y, Zhu J, Bandi V et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003 168 968-975
13. Cosio M G., Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009 360 2445-2454
14. Saetta M, Di Stefano A, Turato G et al. CD8+T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 157 (3 Pt 1) 822-826
15. Hodge S, Hodge G, Nairn J, Holmes M, Reynolds P N. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD 2006 3 179-187
16. Barczyk A, Pierzchaa W, Kon O M., Cosio B, Adcock I M., Barnes P J. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006 117 1484-1492
17. Shaykhiev R, Krause A, Salit J et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009 183 2867-2883
18. Hogg J C., Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004 350 2645-2653
19. Retamales I, Elliott W M., Meshi B et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001 164 469-473
20. Sullivan A K., Simonian P L., Falta M T. et al. Oligoclonal CD4+T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005 172 590-596
21. Grumelli S, Corry D B., Song L Z. et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004 1 e8
22. Di Stefano A, Caramori G, Capelli A et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004 24 78-85 (Pubitemid 39029072)
23. Saetta M, Di Stefano A, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993 147 301-306
24. Finkelstein R, Fraser R S., Ghezzo H, Cosio M G. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995 152 (5 Pt 1) 1666-1672
25. Corthay A. How do regulatory T cells work? Scand J Immunol 2009 70 326-336
26. Barceló B, Pons J, Ferrer J M., Sauleda J, Fuster A, Agustí A G. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008 31 555-562
27. Korn T, Bettelli E, Oukka M, Kuchroo V K. IL-17 and Th17 Cells. Annu Rev Immunol 2009 27 485-517
28. Di Stefano A, Caramori G, Gnemmi I et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 2009 157 316-324
29. Wu C H., Lin H H., Yan F P., Wu C H., Wang C J. Immunohistochemical detection of apoptotic proteins, p53/Bax and JNK/FasL cascade, in the lung of rats exposed to cigarette smoke. Arch Toxicol 2006 80 328-336
30. Park H, Li Z, Yang X O. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005 6 1133-1141
31. Koenen H J., Smeets R L., Vink P M., van Rijssen E, Boots A M., Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008 112 2340-2352
32. Martinez F O., Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009 27 451-483
33. Serbina N V., Jia T, Hohl T M., Pamer E G. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008 26 421-452
34. Hoser G, Domagaa-Kulawik J, Droszcz P, Droszcz W, Kawiak J. Lymphocyte subsets differences in smokers and nonsmokers with primary lung cancer: a flow cytometry analysis of bronchoalveolar lavage fluid cells. Med Sci Monit 2003 9 BR310-BR315
35. Mancini N M., Béné M C., Gérard H et al. Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Lung 1993 171 277-291
36. Soler P, Moreau A, Basset F, Hance A J. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis 1989 139 1112-1117
37. Casolaro M A., Bernaudin J F., Saltini C, Ferrans V J., Crystal R G. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988 137 406-411
38. Tsoumakidou M, Elston W, Zhu J et al. Cigarette smoking alters bronchial mucosal immunity in asthma. Am J Respir Crit Care Med 2007 175 919-925
39. Rogers A V., Adelroth E, Hattotuwa K, Dewar A, Jeffery P K. Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study. Thorax 2008 63 108-114
40. Vassallo R, Tamada K, Lau J S., Kroening P R., Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005 175 2684-2691
41. Robbins C S., Dawe D E., Goncharova S I. et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004 30 202-211
42. D'hulst A I., Vermaelen K Y., Brusselle G G., Joos G F., Pauwels R A. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005 26 204-213
43. Buist A S., Vollmer W M., McBurnie M A. Worldwide burden of COPD in high- and low-income countries, I: The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008 12 703-708
44. Niewoehner D E., Kleinerman J, Rice D B. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974 291 755-758
45. Bosken C H., Hards J, Gatter K, Hogg J C. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992 145 (4 Pt 1) 911-917
46. Lams B E., Sousa A R., Rees P J., Lee T H. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 158 (5 Pt 1) 1518-1523
47. Saetta M, Baraldo S, Corbino L et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 160 711-717
48. Amin K, Ekberg-Jansson A, Löfdahl C G., Venge P. Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study. Thorax 2003 58 135-142
49. Innes A L., Woodruff P G., Ferrando R E. et al. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006 130 1102-1108
50. Saetta M, Turato G, Baraldo S et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000 161 (3 Pt 1) 1016-1021
51. Baraldo S, Saetta M, Cosio M G. Pathophysiology of the small airways. Semin Respir Crit Care Med 2003 24 465-472
52. Wright J L., Hobson J, Wiggs B R., Pare P D., Hogg J C. Effect of cigarette smoking on structure of the small airways. Lung 1987 165 91-100
53. Swan G E., Hodgkin J E., Roby T, Mittman C, Jacobo N, Peters J. Reversibility of airways injury over a 12-month period following smoking cessation. Chest 1992 101 607-612
54. Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 2006 174 853-857
55. Xu X, Dockery D W., Ware J H., Speizer F E., Ferris B G. Jr. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992 146 (5 Pt 1) 1345-1348
56. Anthonisen N R., Connett J E., Kiley J P. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994 272 1497-1505
57. Murray R P., Anthonisen N R., Connett J E. et al, Lung Health Study Research Group. Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. J Clin Epidemiol 1998 51 1317-1326
58. Wright J L., Lawson L M., Pare P D., Wiggs B J., Kennedy S, Hogg J C. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983 127 474-477
59. Rutgers S R., Postma D S., Kauffman H F., Koeter G H., Timens W, ten Hacken N H., van Der Mark T W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Chest 2000 117 (5, Suppl 1) 262S (Pubitemid 30326981)
60. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005 2 258-266 discussion 290-291
61. Sethi S, Mallia P, Johnston S L. New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc Am Thorac Soc 2009 6 532-534
62. Moghaddam S J., Clement C G., De la Garza M M. et al. Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respir Cell Mol Biol 2008 38 629-638
63. Morris A, Sciurba F C., Lebedeva I P. et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004 170 408-413
64. Sethi S, Evans N, Grant B J., Murphy T F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002 347 465-471 (Pubitemid 34879333)
65. Seemungal T, Harper-Owen R, Bhowmik A et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 164 1618-1623
66. Bandi V, Apicella M A., Mason E et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001 164 2114-2119
67. Sethi S. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005 26 192-203 (Pubitemid 40617296)
68. Nathan C, Shiloh M U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 2000 97 8841-8848
69. Daga M K., Chhabra R, Sharma B, Mishra T K. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci 2003 28 7-11
70. Harju T H., Peltoniemi M J., Rytilä P H. et al. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res 2007 8 48
71. Nadeem A, Raj H G., Chhabra S K. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005 29 23-32
72. Kluchová Z, Petrásová D, Joppa P, Dorková Z, Tkácová R. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 2007 56 51-56
73. Kanazawa H, Shiraishi S, Hirata K, Yoshikawa J. Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease. Thorax 2003 58 106-109
74. Gumral N, Naziroglu M, Ongel K et al. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods. Cell Biochem Funct 2009 27 276-283
75. Altunta E, Turgut T, Ilhan N, Deveci F, Muz H M., Celik I. The levels of oxidant and antioxidant in patients with COPD [in Turkish]. Tuberk Toraks 2003 51 373-379
76. Moretti M. Erdosteine: its relevance in COPD treatment. Expert Opin Drug Metab Toxicol 2009 5 333-343
77. Kirkil G, Hamdi Muz M, Seçkin D, Sahin K, Küçük O. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease. Respir Med 2008 102 840-844
78. van Overveld F J., Demkow U, Górecka D, de Backer W A., Zielinski J. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine. J Physiol Pharmacol 2005 56 (Suppl 4) 135-142
79. Massaro G D., Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997 3 675-677 (Pubitemid 27264979)
80. Ishizawa K, Kubo H, Yamada M et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 2004 556 249-252
81. Murakami S, Nagaya N, Itoh T et al. Adrenomedullin regenerates alveoli and vasculature in elastase-induced pulmonary emphysema in mice. Am J Respir Crit Care Med 2005 172 581-589
82. Shigemura N, Sawa Y, Mizuno S et al. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation 2005 111 1407-1414
83. Lucey E C., Goldstein R H., Breuer R, Rexer B N., Ong D E., Snider G L. Retinoic acid does not affect alveolar septation in adult FVB mice with elastase-induced emphysema. Respiration 2003 70 200-205
84. March T H., Cossey P Y., Esparza D C., Dix K J., McDonald J D., Bowen L E. Inhalation administration of all-trans-retinoic acid for treatment of elastase-induced pulmonary emphysema in Fischer 344 rats. Exp Lung Res 2004 30 383-404
85. Roth M D., Connett J E., D'Armiento J M. et al, FORTE Study Investigators. Feasibility of retinoids for the treatment of emphysema study. Chest 2006 130 1334-1345
86. Lian X, Yan C, Yang L, Xu Y, Du H. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am J Physiol Lung Cell Mol Physiol 2004 286 L801-L807
87. Yan C, Du H. Alveolus formation: what have we learned from genetic studies? J Appl Physiol 2004 97 1543-1548
88. Yokohori N, Aoshiba K, Nagai A, Respiratory Failure Research Group in Japan. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004 125 626-632
89. Henson P M., Cosgrove G P., Vandivier R W. State of the art: apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006 3 512-516
90. Kasahara Y, Tuder R M., Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000 106 1311-1319
91. Tang K, Rossiter H B., Wagner P D., Breen E C. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004 97 1559-1566, discussion 1549
92. Tuder R M., Zhen L, Cho C Y. et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003 29 88-97
93. Kasahara Y, Tuder R M., Cool C D., Lynch D A., Flores S C., Voelkel N F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001 163 (3 Pt 1) 737-744
94. Petrache I, Natarajan V, Zhen L et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005 11 491-498
95. Yang S R., Chida A S., Bauter M R. et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006 291 L46-L57
96. Aoshiba K, Tamaoki J, Nagai A. Acute cigarette smoke exposure induces apoptosis of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2001 281 L1392-L1401
97. Kuo W H., Chen J H., Lin H H., Chen B C., Hsu J D., Wang C J. Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/JNK MAPK pathway. Chem Biol Interact 2005 155 31-42
98. Carnevali S, Petruzzelli S, Longoni B et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003 284 L955-L963
99. Taraseviciene-Stewart L, Scerbavicius R, Choe K H. et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005 171 734-742
100. Feghali-Bostwick C A., Gadgil A S., Otterbein L E. et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 177 156-163